美国安进地舒单抗注射液可用来治疗什么病症
What conditions can Amgen injection be used to treat? Desosumab injection is produced by Amgen of the United States. On May 28, 2010, the European Commission approved denosumab for the treatment of bone loss associated with hormone suppression in postmenopausal women with osteoporosis and prostate cancer. It can also be used in patients who are currently ineffective or intolerant to other treatments to reduce the risk of fractures.
Amgen is one of the world's leading independent biotechnology companies. Founded in 1980, it provides innovative drugs to millions of patients in more than 100 countries and regions around the world, and also has a number of potential drugs under development. Amgen entered China in 2012, and its Chinese headquarters is located in Shanghai. On May 27, 2019, Amgen China announced that denosumab has been approved by the National Medical Products Administration for the treatment of giant cell tumors of bone that are unresectable or whose surgical resection may cause severe functional disability, including adults and adolescent patients with skeletal maturity (defined as at least 1 mature long bone and a body weight ≥45 kg).
The recommended dose of denosumab for the prevention of bone-related events in solid tumor bone metastases is 120 mg, administered by subcutaneous injection (upper arm, upper thigh, or abdomen) once every 4 weeks, along with calcium or vitamin D infusion to prevent hypocalcemia. NOTE: Not for use in patients with multiple myeloma for prophylaxis of bone-related events.
It is a prescription drug and patients should not take it blindly. Hypocalcemia must be corrected before treatment can be initiated. For some special groups, such as pregnant women, the use of denosumab may cause fetal damage; breastfeeding women need to choose to terminate the drug or breastfeed; the safety and effectiveness of the drug in pediatric patients have not yet been determined. Patients need to use it under the guidance of a doctor, and if they have other special circumstances, they need to inform the doctor in advance.
Recommended related hot articles: /newsDetail/91077.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)